These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 20008677)
1. DC-SCRIPT: nuclear receptor modulation and prognostic significance in primary breast cancer. Ansems M; Hontelez S; Looman MW; Karthaus N; Bult P; Bonenkamp JJ; Jansen JH; Sweep FC; Span PN; Adema GJ J Natl Cancer Inst; 2010 Jan; 102(1):54-68. PubMed ID: 20008677 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study. Sieuwerts AM; Ansems M; Look MP; Span PN; de Weerd V; van Galen A; Foekens JA; Adema GJ; Martens JW Breast Cancer Res; 2010; 12(6):R103. PubMed ID: 21122099 [TBL] [Abstract][Full Text] [Related]
3. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial. Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363 [TBL] [Abstract][Full Text] [Related]
4. Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer. Tong D; Schneeberger C; Czerwenka K; Schmutzler RK; Speiser P; Kucera E; Concin N; Kubista E; Leodolter S; Zeillinger R Clin Cancer Res; 1999 Jun; 5(6):1497-502. PubMed ID: 10389938 [TBL] [Abstract][Full Text] [Related]
5. Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer. Davies MP; Barraclough DL; Stewart C; Joyce KA; Eccles RM; Barraclough R; Rudland PS; Sibson DR Int J Cancer; 2008 Jul; 123(1):85-8. PubMed ID: 18386815 [TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046 [TBL] [Abstract][Full Text] [Related]
7. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen. Girault I; Lerebours F; Amarir S; Tozlu S; Tubiana-Hulin M; Lidereau R; Bièche I Clin Cancer Res; 2003 Apr; 9(4):1259-66. PubMed ID: 12684393 [TBL] [Abstract][Full Text] [Related]
8. Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients. Sicking I; Rommens K; Battista MJ; Böhm D; Gebhard S; Lebrecht A; Cotarelo C; Hoffmann G; Hengstler JG; Schmidt M BMC Cancer; 2014 Dec; 14():952. PubMed ID: 25511800 [TBL] [Abstract][Full Text] [Related]
9. Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer. Pérez-Gómez E; Andradas C; Blasco-Benito S; Caffarel MM; García-Taboada E; Villa-Morales M; Moreno E; Hamann S; Martín-Villar E; Flores JM; Wenners A; Alkatout I; Klapper W; Röcken C; Bronsert P; Stickeler E; Staebler A; Bauer M; Arnold N; Soriano J; Pérez-Martínez M; Megías D; Moreno-Bueno G; Ortega-Gutiérrez S; Artola M; Vázquez-Villa H; Quintanilla M; Fernández-Piqueras J; Canela EI; McCormick PJ; Guzmán M; Sánchez C J Natl Cancer Inst; 2015 Jun; 107(6):djv077. PubMed ID: 25855725 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study. Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554 [TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor-alpha mRNA in primary breast cancer: relationship to estrogen and progesterone receptor proteins and other prognostic factors. Chearskul S; Bhothisuwan K; Churintrapun M; Semprasert N; Onreabroi S Asian Pac J Allergy Immunol; 2002 Mar; 20(1):13-21. PubMed ID: 12125913 [TBL] [Abstract][Full Text] [Related]
12. Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98. Viale G; Regan MM; Maiorano E; Mastropasqua MG; Dell'Orto P; Rasmussen BB; Raffoul J; Neven P; Orosz Z; Braye S; Ohlschlegel C; Thürlimann B; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS J Clin Oncol; 2007 Sep; 25(25):3846-52. PubMed ID: 17679725 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial. Linardou H; Kalogeras KT; Kronenwett R; Alexopoulou Z; Wirtz RM; Zagouri F; Scopa CD; Gogas H; Petraki K; Christodoulou C; Pavlakis K; Koutras AK; Samantas E; Patsea H; Pectasides D; Bafaloukos D; Fountzilas G Anticancer Res; 2015 Jul; 35(7):4023-36. PubMed ID: 26124351 [TBL] [Abstract][Full Text] [Related]
14. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis. Kobayashi T; Tsuda H; Moriya T; Yamasaki T; Kikuchi R; Ueda S; Omata J; Yamamoto J; Matsubara O Breast Cancer Res Treat; 2010 Oct; 123(3):733-45. PubMed ID: 20020198 [TBL] [Abstract][Full Text] [Related]
15. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer. Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243 [TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification. Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097 [TBL] [Abstract][Full Text] [Related]
17. DC-SCRIPT: AR and VDR regulator lost upon transformation of prostate epithelial cells. Ansems M; Karthaus N; Hontelez S; Aalders T; Looman MW; Verhaegh GW; Schalken JA; Adema GJ Prostate; 2012 Dec; 72(16):1708-17. PubMed ID: 22473304 [TBL] [Abstract][Full Text] [Related]
18. Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology. Jacobsen BM; Schittone SA; Richer JK; Horwitz KB Mol Endocrinol; 2005 Mar; 19(3):574-87. PubMed ID: 15563544 [TBL] [Abstract][Full Text] [Related]
19. Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients. Liu S; Chia SK; Mehl E; Leung S; Rajput A; Cheang MC; Nielsen TO Breast Cancer Res Treat; 2010 Jan; 119(1):53-61. PubMed ID: 19205877 [TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer? Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]